Deborah Dunsire kicks off her new gig as Lundbeck CEO with a key PhIII trial failure
You have to feel almost sorry for Deborah Dunsire.
No sooner does the Millennium vet take the helm of Lundbeck after back-to-back biotechs collapse on …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
